These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 53140)

  • 21. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 22. Spectrum analysis of electroencephalographic changes induced by some psychoactive agents. Their possible relationship to changes in cerebral biogenic amine levels.
    Eidelberg E; Miller MK; Long M
    Int J Neuropharmacol; 1966 Jan; 5(1):59-74. PubMed ID: 4380483
    [No Abstract]   [Full Text] [Related]  

  • 23. Central transmitter involvement in LON-954-induced tremorogenesis.
    Coward DM; Doggett NS; Thomas JE
    Neuropharmacology; 1977; 16(7-8):479-84. PubMed ID: 144244
    [No Abstract]   [Full Text] [Related]  

  • 24. Interactions of imipramine and synthesis inhibitors on biogenic amines.
    Friedman E; Shopsin B; Goldstein M; Gershon S
    J Pharm Pharmacol; 1974 Dec; 26(12):995-6. PubMed ID: 4156872
    [No Abstract]   [Full Text] [Related]  

  • 25. The selective effects of alpha-methyl aromatic amino acids on brain monoamine metabolites and behavior in cats.
    Buckingham RL; Radulovacki M
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):255-65. PubMed ID: 1197913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on psychotropic drugs. XX. Effects of 1-methyl-5-o-chlorophenyl-7-ethyl-1,2-dihydro-3H-thieno[2,3-e][1,4]diazepin-2-one (Y-6047) on the metabolism of biogenic amines.
    Nakanishi M; Setoguchi M
    Arzneimittelforschung; 1972 Nov; 22(11):1914-8. PubMed ID: 4267010
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of alpha-methyl-p-tyrosine upon cerebral amine metabolism and sleep states in the cat.
    Stein D; Jouvet M; Pujol JF
    Brain Res; 1974 Jun; 72(2):360-5. PubMed ID: 4838386
    [No Abstract]   [Full Text] [Related]  

  • 28. Biogenic amines and affective disorders. A critical analysis.
    Luchins D
    Int Pharmacopsychiatry; 1976; 11(3):135-49. PubMed ID: 136425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behaviour of rats and biogenic amine level in brain after 6-hydroxy-dopamine.
    Herman ZS; Kmieciak-Kolada K; Brus R
    Psychopharmacologia; 1972; 24(3):407-16. PubMed ID: 5034941
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonergic inhibition of catecholamine-induced behavioral arousal.
    Mabry PD; Campbell BA
    Brain Res; 1973 Jan; 49(2):381-91. PubMed ID: 4269051
    [No Abstract]   [Full Text] [Related]  

  • 31. Simulation of biogenic amine metabolism in the brain.
    Turner AJ; Illingworth JA; Tipton KF
    Biochem J; 1974 Nov; 144(2):353-60. PubMed ID: 4618480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective protection of 5-hydroxytryptamine stores against the action of reserpine by treatment with 5-hydroxytryptophan.
    Carlsson A
    J Pharm Pharmacol; 1967 Nov; 19(11):783-4. PubMed ID: 4383709
    [No Abstract]   [Full Text] [Related]  

  • 33. Pancreatic biogenic amines and insulin secretion in health and disease.
    Lebovitz HE; Feldman JM
    Fed Proc; 1973 Jul; 32(7):1797-802. PubMed ID: 4198098
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of various tricyclic antidepressants on amine uptake.
    Ishikawa K; Shibanoki S; Kubo T; Watabe S; Matsumoto A; Kogure M
    Eur J Pharmacol; 1986 Jan; 120(1):63-8. PubMed ID: 2936613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of tandamine, a new potential antidepressant agent, on biogenic amine uptake mechanisms and related activities.
    Lippmann W; Pugsley TA
    Biochem Pharmacol; 1976 May; 25(10):1179-86. PubMed ID: 1084746
    [No Abstract]   [Full Text] [Related]  

  • 36. Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
    Hershkowitz M; Szechtman H
    Eur J Pharmacol; 1979 Nov; 59(3-4):267-76. PubMed ID: 230975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of biogenic amines to behavior.
    Breese GR; Cooper BR; Hollister AS
    J Psychiatr Res; 1974; 11():125-33. PubMed ID: 4282384
    [No Abstract]   [Full Text] [Related]  

  • 38. Rat strain differences in brain monoamine metabolism following para-chlorophenylalanine treatment.
    Emery D; Engel J; Larsson K
    Pharmacol Biochem Behav; 1980 Feb; 12(2):311-2. PubMed ID: 6445566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):79-93. PubMed ID: 5072194
    [No Abstract]   [Full Text] [Related]  

  • 40. Learned escape behavior induced by brain electrical stimulation and various neuroactive agents.
    Wada JA; Matsuda M
    Exp Neurol; 1971 Sep; 32(3):357-65. PubMed ID: 4255640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.